[Frequency of hematologic side effects in antihypertensive long-term therapy].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000974:Antibodies, Antinuclear; D000959:Antihypertensive Agents / Q000009:adverse effects*; D001161:Arteriosclerosis / Q000150:complications; D001772:Blood Cell Count; D004906:Erythrocyte Count; D005260:Female; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects; D006973:Hypertension / Q000188:drug therapy; D006977:Hypertension, Renal / Q000188:drug therapy; D007958:Leukocyte Count; D008134:Long-Term Care; D008297:Male; D008750:Methyldopa / Q000009:adverse effects; D008875:Middle Aged; D013997:Time Factors
D000974:Antibodies, Antinuclear; D000959:Antihypertensive Agents; D006830:Hydralazine; D008750:Methyldopa
Zur Häufigkeit hämatologischer Nebenwirkungen bei antihypertensiver Langzeittherapie.